Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Table of Contents

May 2021; Volume 41,Issue 5

Reviews

  • You have access
    Current Update on the Diagnosis, Management and Pathogenesis of Elastofibroma Dorsi
    JUN NISHIO, SHIZUHIDE NAKAYAMA, KAZUKI NABESHIMA and TAKUAKI YAMAMOTO
    Anticancer Research May 2021, 41 (5) 2211-2215; DOI: https://doi.org/10.21873/anticanres.14997
  • You have access
    Medical Thoracoscopy, Computed Tomography-guided Biopsy, and Ultrasound-guided Biopsy for Malignant Pleural Mesothelioma: A Systematic Review
    AKIHIRO SHIROSHITA, MOTOHIRO KUROSAKI, MASAFUMI TAKESHITA and YUKI KATAOKA
    Anticancer Research May 2021, 41 (5) 2217-2225; DOI: https://doi.org/10.21873/anticanres.14998
  • You have access
    Obesity and Liver Cancer in Japan: A Comprehensive Review
    HIROKI NISHIKAWA, SHINYA FUKUNISHI, AKIRA ASAI, SHUHEI NISHIGUCHI and KAZUHIDE HIGUCHI
    Anticancer Research May 2021, 41 (5) 2227-2237; DOI: https://doi.org/10.21873/anticanres.14999

Experimental Studies

  • You have access
    IL-39 Reduces Proliferation and Promotes Apoptosis of Bladder Cancer by Altering the Activity of Cyclin E and Fas
    HUAPING XIAO, HAMZA ALISIC, BRANDON T. REIMAN, ZULIANG DENG, ZIWEN ZHU, NATHAN T. GIVENS, QIAN BAI, ANDREW TAIT, MARK R. WAKEFIELD and YUJIANG FANG
    Anticancer Research May 2021, 41 (5) 2239-2245; DOI: https://doi.org/10.21873/anticanres.15000
  • You have access
    Evaluation of the Cytotoxic Effects of the Novel Antineoplastic Agent 1,4,5-Oxathiazinane-4,4-dioxide on Triple Negative Breast Cancer Cells
    MARCEL JINIH, JIANG HUAI WANG, ROLF W. PFIRRMANN, D. PETER O’LEARY, MARK A. CORRIGAN and H. PAUL REDMOND
    Anticancer Research May 2021, 41 (5) 2247-2256; DOI: https://doi.org/10.21873/anticanres.15001
  • You have access
    Combined Targeting of AKT and mTOR Synergistically Inhibits Formation of Primary Colorectal Carcinoma Tumouroids In Vitro: A 3D Tumour Model for Pre-therapeutic Drug Screening
    DOMINIK NÖRZ, CHRISTINA S. MULLINS, DANIEL J. SMIT, MICHAEL LINNEBACHER, GRITH HAGEL, ALP MIRDOGAN, JACQUELINE SIEKIERA, PATRICK EHM, JAKOB R. IZBICKI, ANDREAS BLOCK, OLE THASTRUP and MANFRED JÜCKER
    Anticancer Research May 2021, 41 (5) 2257-2275; DOI: https://doi.org/10.21873/anticanres.15002
  • You have access
    Synergistic Effect of Bazedoxifene and PARP Inhibitor in the Treatment of Ovarian Cancer Regardless of BRCA Mutation
    RUIJIE ZHANG, TIFFANY WANG and JIAYUH LIN
    Anticancer Research May 2021, 41 (5) 2277-2286; DOI: https://doi.org/10.21873/anticanres.15003
  • You have access
    Structure-activity Relationship of Indomethacin Derivatives as IDO1 Inhibitors
    TOHRU OBATA, SARA SHIRATANI, TOMOMI NADA, YAYOI KASAYA, MITSUHIRO ARISAWA, SATOSHI SHUTO and MOTOHIRO TANAKA
    Anticancer Research May 2021, 41 (5) 2287-2296; DOI: https://doi.org/10.21873/anticanres.15004
  • You have access
    Over-expression of PDE5 in Oral Squamous Cell Carcinoma – Effect of Sildenafil Citrate
    TAKAHIRO IWASAKI, TAKESHI ONDA, HIRONA HONDA, KAMICHIKA HAYASHI, TAKAHIKO SHIBAHARA, TAKESHI NOMURA and MASAYUKI TAKANO
    Anticancer Research May 2021, 41 (5) 2297-2306; DOI: https://doi.org/10.21873/anticanres.15005
  • You have access
    Retinoids Decrease Soluble MICA Concentration by Inhibiting the Enzymatic Activity of ADAM9 and ADAM10
    YUMI OTOYAMA, JUN ARAI, KAKU GOTO, HISAKO NOZAWA, RYO NAKAGAWA, RYOSUKE MUROYAMA, IKUYA SUGIURA, YOKO NAKAJIMA, ATSUSHI KAJIWARA, MASAYUKI TOJO, YUKI ICHIKAWA, SHOJIRO UOZUMI, YUU SHIMOZUMA, MANABU UCHIKOSHI, MASASHI SAKAKI, NAOYA KATO and HITOSHI YOSHIDA
    Anticancer Research May 2021, 41 (5) 2307-2320; DOI: https://doi.org/10.21873/anticanres.15006
  • You have access
    Involvement of Galectin-1 Tumor Microenvironment in Radiosensitivity
    YI-FAN CHEN, CHUNG-CHI WANG, CHIEH-YING HSU and ENG-YEN HUANG
    Anticancer Research May 2021, 41 (5) 2321-2331; DOI: https://doi.org/10.21873/anticanres.15007
  • You have access
    Establishment of a Novel Temozolomide Resistant Subline of Glioblastoma Multiforme Cells and Comparative Transcriptome Analysis With Parental Cells
    HAI-ANH HA, JAI-SING YANG, FUU-JEN TSAI, CHANG-WEI LI, YIH-DIH CHENG, JIANYONG LI, MANN-JEN HOUR and YU-JEN CHIU
    Anticancer Research May 2021, 41 (5) 2333-2347; DOI: https://doi.org/10.21873/anticanres.15008
  • You have access
    Expression of Lysophosphatidylinositol Signaling-relevant Molecules in Colorectal Cancer
    CHIEKO KITAMURA, HIROFUMI SONODA, HIROYUKI ANZAI, YUZO NAGAI, SHINYA ABE, YUICHIRO YOKOYAMA, HIROAKI ISHII, JUNKO KISHIKAWA, SHIGENOBU EMOTO, KOJI MURONO, KAZUHITO SASAKI, KAZUSHIGE KAWAI, HIROAKI NOZAWA and SOICHIRO ISHIHARA
    Anticancer Research May 2021, 41 (5) 2349-2355; DOI: https://doi.org/10.21873/anticanres.15009
  • You have access
    Expression of Death Associated Proteins DAP1 and DAP3 in Human Pancreatic Cancer
    LAIJIAN SUI, LIN YE, ANDREW J. SANDERS, YIMING YANG, CHUNYI HAO, RACHEL HARGEST and WEN G. JIANG
    Anticancer Research May 2021, 41 (5) 2357-2362; DOI: https://doi.org/10.21873/anticanres.15010
  • You have access
    Comparative Evaluation of Cellular Uptake of Free and Liposomal Doxorubicin Following Short Term Exposure
    GINTARAS ZALESKIS, SIMA GARBERYTE, BOZENA PAVLIUKEVICIENE, JAN ALEKSANDER KRASKO, MARTYNAS SKAPAS, MARTYNAS TALAIKIS, ADAS DARINSKAS, LAVIJA ZIBUTYTE and VITA PASUKONIENE
    Anticancer Research May 2021, 41 (5) 2363-2370; DOI: https://doi.org/10.21873/anticanres.15011
  • You have access
    Estrogen Receptor β Is Involved in Acquired Resistance to EGFR-tyrosine Kinase Inhibitors in Lung Cancer
    HIROKI SUGIURA, YASUHIRO MIKI, ERINA IWABUCHI, RYOKO SAITO, KATSUHIKO ONO, IKURO SATO, YOSHINORI OKADA and HIRONOBU SASANO
    Anticancer Research May 2021, 41 (5) 2371-2381; DOI: https://doi.org/10.21873/anticanres.15012
  • You have access
    Modulation of Apoptosis and Epithelial-Mesenchymal Transition E-cadherin/TGF-β/Snail/TWIST Pathways by a New Ciprofloxacin Chalcone in Breast Cancer Cells
    RANIA ALAAELDIN, GAMAL EL-DIN A. ABUO-RAHMA, QING-LI ZHAO and MOUSTAFA FATHY
    Anticancer Research May 2021, 41 (5) 2383-2395; DOI: https://doi.org/10.21873/anticanres.15013
  • You have access
    PARP1 Is Overexpressed in Hematological Malignant Cell Lines: A Framework for Experimental Oncology
    CAIO BEZERRA MACHADO, EMERSON LUCENA DA SILVA, BEATRIZ MARIA DIAS NOGUEIRA, MANOEL ODORICO DE MORAES FILHO, RAQUEL CARVALHO MONTENEGRO, MARIA ELISABETE AMARAL DE MORAES and CAROLINE AQUINO MOREIRA-NUNES
    Anticancer Research May 2021, 41 (5) 2397-2402; DOI: https://doi.org/10.21873/anticanres.15014
  • You have access
    Fascin Regulates the Hippo Pathway and Is Important for Melanoma Development
    BYUNG-SOO KANG and SUNG-CHUL LIM
    Anticancer Research May 2021, 41 (5) 2403-2410; DOI: https://doi.org/10.21873/anticanres.15015
  • You have access
    miRNA-93 in Serum Extracellular Vesicles Before and After Low Dose Rate Prostate Brachytherapy
    KOJI IINUMA, KYOJIRO KAWAKAMI, KOSUKE MIZUTANI, YASUNORI FUJITA, TAKAHIRO YAMAGUCHI, MASAYA ITO, TOMOYASU KUMANO, MASAYUKI MATSUO, MASAHIRO NAKANO, TAKUYA KOIE, MASAFUMI ITO and TAKU KATO
    Anticancer Research May 2021, 41 (5) 2411-2418; DOI: https://doi.org/10.21873/anticanres.15016
  • You have access
    Prediction of Chemosensitivity in Multiple Primary Cancer Patients Using Machine Learning
    XIANGLAN ZHANG, MI JANG, ZHENLONG ZHENG, AIHUA GAO, ZHENHUA LIN and KI-YEOL KIM
    Anticancer Research May 2021, 41 (5) 2419-2429; DOI: https://doi.org/10.21873/anticanres.15017
  • You have access
    A TGFβ Signaling Inhibitor, SB431542, Inhibits Reovirus-mediated Lysis of Human Hepatocellular Carcinoma Cells in a TGFβ-independent Manner
    IKUHO ISHIGAMI, NAOMI SHUWARI, TADATAKA KAMINADE, HIROYUKI MIZUGUCHI and FUMINORI SAKURAI
    Anticancer Research May 2021, 41 (5) 2431-2440; DOI: https://doi.org/10.21873/anticanres.15018
  • You have access
    MiR-3663-3p Inhibits the Progression of Gastric Cancer Through the CCND1 Pathway
    KOJI TAKAO, HIROTAKA KONISHI, DAIKI MATSUBARA, KATSUTOSHI SHODA, TOMOHIRO ARITA, HIROKI SHIMIZU, SHUHEI KOMATSU, ATSUSHI SHIOZAKI, YUSUKE YAMAMOTO, TAKESHI KUBOTA, HITOSHI FUJIWARA, KAZUMA OKAMOTO and EIGO OTSUJI
    Anticancer Research May 2021, 41 (5) 2441-2449; DOI: https://doi.org/10.21873/anticanres.15019
  • You have access
    Contribution of Interleukin-10 Genotype to Triple Negative Breast Cancer Risk
    KAI-YUAN CHEN, WEI-CHING CHIEN, JIUAN-MIAW LIAO, CHIA-WEN TSAI, WEN-SHIN CHANG, CHEN-HSIEN SU, SHIH-WEI HSU, HWEI-CHUNG WANG and DA-TIAN BAU
    Anticancer Research May 2021, 41 (5) 2451-2457; DOI: https://doi.org/10.21873/anticanres.15020

Clinical Studies

  • You have access
    Pretreatment MRI in Primary Rectal Cancer as a Predictor for Oncological Outcomes After Surgery for Local Recurrence
    ANDERS H. ELLIOT, BARWAR N. OTHMAN, CHIKAKO SUZUKI, LENNART BLOMQVIST, ANNA MARTLING, HEMMING JOHANSSON, BENGT GLIMELIUS, PER J. NILSSON and HENRIK IVERSEN
    Anticancer Research May 2021, 41 (5) 2459-2465; DOI: https://doi.org/10.21873/anticanres.15021
  • You have access
    Adaptive Radiation Therapy for Intact Thymoma: An Illustrative Report
    NEIL CHEVLI, ROSS E. BLAND, ANDREW M. FARACH, RAMIRO PINO, THOMAS MATHEWS, EKENE I. OKOYE, SHANDA BLACKMON, E. BRIAN BUTLER and BIN S. TEH
    Anticancer Research May 2021, 41 (5) 2467-2471; DOI: https://doi.org/10.21873/anticanres.15022
  • You have access
    What Is the Clinical Impact of Sending Tissue for Histopathology During Surgery for Known, Diffuse Metastatic Disease to Bone?
    CHARLES A. GUSHO and ALAN T. BLANK
    Anticancer Research May 2021, 41 (5) 2473-2476; DOI: https://doi.org/10.21873/anticanres.15023
  • You have access
    Diagnostic Role of PET/CT Tracers in the Detection and Localization of Tumours Responsible for Ectopic Cushing’s Syndrome
    LUCIA ZISSER, OANA C. KULTERER, BIANCA ITARIU, BARBARA FUEGER, MICHAEL WEBER, PETER MAZAL, CHRYSOULA VRAKA, VERENA PICHLER, ALEXANDRA KAUTZKY-WILLER, MARCUS HACKER, GEORGIOS KARANIKAS and SAZAN RASUL
    Anticancer Research May 2021, 41 (5) 2477-2484; DOI: https://doi.org/10.21873/anticanres.15024
  • You have access
    Cutaneous Lesion of the Nose as Initial Presentation of Esophageal Adenocarcinoma
    AARON HAAG, DEANNA HUFFMAN, CHELSEA PETERSON, KARTHIK SHANKAR, LYNNA ALNIMER, YAZAN SAMHOURI and LARISA GREENBERG
    Anticancer Research May 2021, 41 (5) 2485-2488; DOI: https://doi.org/10.21873/anticanres.15025
  • You have access
    Sleep Disorders in Patients With Breast Cancer Prior to a Course of Radiotherapy – Prevalence and Risk Factors
    DIRK RADES, CARLOS A. NARVAEZ, LIESA DZIGGEL, SOEREN TVILSTED and TROELS W. KJAER
    Anticancer Research May 2021, 41 (5) 2489-2494; DOI: https://doi.org/10.21873/anticanres.15026
  • You have access
    Karnofsky Performance Score – An Independent Prognostic Factor of Survival After Palliative Irradiation for Sino-nasal Cancer
    DIRK RADES, CHRISTIAN STAACKMANN and STEVEN E. SCHILD
    Anticancer Research May 2021, 41 (5) 2495-2499; DOI: https://doi.org/10.21873/anticanres.15027
  • You have access
    PD-L1 Expression Status Predicting Survival in Pulmonary Pleomorphic Carcinoma
    KAKERU HISAKANE, MASAHIRO SEIKE, TEPPEI SUGANO, KUNIKO MATSUDA, SHINOBU KUNUGI, SHINJI NAKAMICHI, MASARU MATSUMOTO, AKIHIKO MIYANAGA, RINTARO NORO, YUJI MINEGISHI, KAORU KUBOTA and AKIHIKO GEMMA
    Anticancer Research May 2021, 41 (5) 2501-2509; DOI: https://doi.org/10.21873/anticanres.15028
  • You have access
    Relevance of CYP3A5 Expression on the Clinical Outcome of Patients With Renal Cell Carcinoma
    JUN MATSUMOTO, YUMI KOTERA, SHOGO WATARI, KOICHI TAKEUCHI, HIDEO UEKI, TOSHIHIRO KOYAMA, KOICHIRO WADA, MASACHIKA FUJIYOSHI, YASUTOMO NASU and NORITAKA ARIYOSHI
    Anticancer Research May 2021, 41 (5) 2511-2521; DOI: https://doi.org/10.21873/anticanres.15029
  • You have access
    Comparison of Physician-recorded Toxicities and Patient-reported Outcomes of Five Different Radiotherapy Methods for Prostate Cancer
    MAKOTO ITO, KAZUMA SASAMURA, YUUKI TAKASE, TADAYUKI KOTSUMA, YUKIHIKO OSHIMA, YOSHITAKA MINAMI, JUNJI SUZUKI, EIICHI TANAKA, WATARU OHASHI, MASAHIKO OGUCHI, TAKAHITO OKUDA, KOJIRO SUZUKI and YASUO YOSHIOKA
    Anticancer Research May 2021, 41 (5) 2523-2531; DOI: https://doi.org/10.21873/anticanres.15030
  • You have access
    Impact of Inferior Mesenteric Artery Lymph Node Metastasis on the Prognosis of Left-sided Colorectal Cancer
    KAZUYA TAKABATAKE, TOMOHIRO ARITA, MASAYOSHI NAKANISHI, YOSHIAKI KURIU, YASUTOSHI MURAYAMA, HIROKI SHIMIZU, MICHIHIRO KUDOU, JUN KIUCHI, TOSHIYUKI KOSUGA, HIROTAKA KONISHI, RYO MORIMURA, ATSUSHI SHIOZAKI, HISASHI IKOMA, TAKESHI KUBOTA, HITOSHI FUJIWARA, KAZUMA OKAMOTO and EIGO OTSUJI
    Anticancer Research May 2021, 41 (5) 2533-2542; DOI: https://doi.org/10.21873/anticanres.15031
  • You have access
    Cytoplasmic-only Expression of Maspin Predicts Unfavorable Prognosis in Patients With Pancreatic Ductal Adenocarcinoma
    EI UCHINAKA, TOMOHIKO SAKABE, TAKEHIKO HANAKI, NARUO TOKUYASU, TERUHISA SAKAMOTO, SOICHIRO HONJO, YOSHIYUKI FUJIWARA and YOSHIHISA UMEKITA
    Anticancer Research May 2021, 41 (5) 2543-2552; DOI: https://doi.org/10.21873/anticanres.15032
  • You have access
    Regorafenib-to-trifluridine/tipiracil Versus the Reverse Sequence for Refractory Metastatic Colorectal Cancer Patients: A Multicenter Retrospective Real-life Experience
    CARLO SIGNORELLI, DONATELLO GEMMA, ROBERTA GRANDE, SALVATORE DE MARCO, ROSA SALTARELLI, MARIA GRAZIA MORANDI, GIAN PAOLO SPINELLI, FEDERICA ZORATTO, ISABELLA SPERDUTI, MARIO GIOVANNI CHILELLI, ANNA CERIBELLI and ENZO MARIA RUGGERI
    Anticancer Research May 2021, 41 (5) 2553-2561; DOI: https://doi.org/10.21873/anticanres.15033
  • You have access
    Prognosis of Patients With Interstitial Lung Disease Induced by Different Pharmacological Types of Anticancer Drugs
    KOHEI IWASHITA, TOMOHIRO MIZUNO, SATOMI KUMAZAWA, KAZUYOSHI IMAIZUMI and SHIGEKI YAMADA
    Anticancer Research May 2021, 41 (5) 2563-2568; DOI: https://doi.org/10.21873/anticanres.15034
  • You have access
    Tolerability of Molecular-targeted Agents for Hepatocellular Carcinoma Treatment in Haemophiliacs
    TAKAFUMI YAMAMOTO, NORIHIRO IMAI, KENTA YAMAMOTO, TAKANORI ITO, YOJI ISHIZU, TAKASHI HONDA, SHUICHI OKAMOTO, TAKESHI KANEMATSU, NOBUAKI SUZUKI, TADASHI MATSUSHITA, MASATOSHI ISHIGAMI and MITSUHIRO FUJISHIRO
    Anticancer Research May 2021, 41 (5) 2569-2573; DOI: https://doi.org/10.21873/anticanres.15035
  • You have access
    Effective Control of Brain Metastases Irrespective of Distance from Isocenter in Single-isocenter Multitarget Stereotactic Radiosurgery
    KEN AOKI, YUKIHIRO NAGATANI, KAZUO NOMA, TAKUYA TSUGAWA, NAOAKI KONO, YUKAKO KIDA, NAOKI HARADA, YOSHIHIDE TANOUE and YOSHIYUKI WATANABE
    Anticancer Research May 2021, 41 (5) 2575-2581; DOI: https://doi.org/10.21873/anticanres.15036
  • You have access
    Brainstem Infiltration Predicts Survival in Patients With High-grade Gliomas Treated With Chemoradiotherapy
    SHIMPEI ANAMI, JUNYA FUKAI, MIZUKI HAMA, AZUSA AWAYA, TAKAYA INAGAKI, TAKAHIRO CHIBA, YASUTAKA NODA, YONEHIRO KANEMURA, NAOYUKI NAKAO and TETSUO SONOMURA
    Anticancer Research May 2021, 41 (5) 2583-2589; DOI: https://doi.org/10.21873/anticanres.15037
  • You have access
    Switching from Intravenous to Oral Tacrolimus Reduces its Blood Concentration in Paediatric Cancer Patients
    HARUKI UJIIE, SATORU NIHEI, NAOYUKI NISHIYA, SHINPEI GOTO, YOSHIKO ASAKURA, SHOKO MIURA, DAISHI HIRAI, MIKIYA ENDO, TATSUO OYAKE, SHIGEKI ITO, TAKESHI CHIBA and KENZO KUDO
    Anticancer Research May 2021, 41 (5) 2591-2596; DOI: https://doi.org/10.21873/anticanres.15038
  • You have access
    Comparison of Chemotherapeutic Regimens Frequently Used in Metastatic Non-squamous NSCLC Treatment
    DANIEL KREJCI, PETR OPALKA, JANA KREJCI, MILADA ZEMANOVA, PETRA ZEMANOVA, JURAJ KULTAN, ONDREJ FISCHER, JANA SKRICKOVA, MONIKA BRATOVA, MARKETA CERNOVSKA, MICHAL HRNCIARIK, HELENA COUPKOVA, KAROLINA HURDALKOVA, MAGDA BARINOVA, LEONA KOUBKOVA, DANIEL DOLEZAL, MARTIN SAFANDA, MILOS PESEK and MARTIN SVATON
    Anticancer Research May 2021, 41 (5) 2597-2603; DOI: https://doi.org/10.21873/anticanres.15039
  • You have access
    Elevated Postoperative Levels of Serum C-reactive Protein Are Associated With Shorter Long-term Survival After Resection of Colorectal Liver Metastases, Regardless of the Occurrence of Infectious Complications
    MASATSUNE SHIBUTANI, KENJIRO KIMURA, SHINICHIRO KASHIWAGI, EN WANG, YUKI OKAZAKI, KIYOSHI MAEDA, KOSEI HIRAKAWA and MASAICHI OHIRA
    Anticancer Research May 2021, 41 (5) 2605-2610; DOI: https://doi.org/10.21873/anticanres.15040
  • You have access
    Laparoscopic Surgery Is Acceptable for Elderly Patients With Colorectal Cancer: A Propensity Score-matched Study
    MAKOTO TAKAHASHI, KAZUHIRO SAKAMOTO, TAKAHIRO IRIE, SHINGO KAWANO, KIICHI SUGIMOTO, YUTAKA KOJIMA, SHUKO NOJIRI, ATSUSHI OKUZAWA and YUICHI TOMIKI
    Anticancer Research May 2021, 41 (5) 2611-2615; DOI: https://doi.org/10.21873/anticanres.15041
  • You have access
    Potential Benefits of Minimally Invasive Laparoscopy in Reducing Local Recurrence After Surgery for Low Rectal Cancer
    MASAKATSU NUMATA, HIROSHI TAMAGAWA, KEISUKE KAZAMA, YOSUKE ATSUMI, KENTA IGUCHI, SHO SAWAZAKI, TORU AOYAMA, SUMITO SATO, NOBUHIRO SUGANO, TENI GODAI, AKIO HIGUCHI, YUSUKE SAIGUSA, HIROYUKI SAEKI, TAKANOBU YAMADA, TAKASHI OSHIMA, MANABU SHIOZAWA, NORIO YUKAWA and YASUSHI RINO
    Anticancer Research May 2021, 41 (5) 2617-2623; DOI: https://doi.org/10.21873/anticanres.15042
  • You have access
    Yttrium-90 Radioembolization for Hepatocellular Carcinoma: Virtual Tumor Absorbed Dose as a Predictor of Complete Response
    HYO-CHEOL KIM, JIN WOO CHOI, MYUNGSU LEE, YOON JUN KIM, JIN CHUL PAENG and JIN WOOK CHUNG
    Anticancer Research May 2021, 41 (5) 2625-2635; DOI: https://doi.org/10.21873/anticanres.15043
  • You have access
    Heart Rate Variability as a Non-invasive Objective Parameter for Predicting the Occurrence of Chemotherapy-induced Peripheral Neuropathy in Patients With Gastrointestinal Cancer
    AELEE JANG and YOUNG MI SEOL
    Anticancer Research May 2021, 41 (5) 2637-2645; DOI: https://doi.org/10.21873/anticanres.15044
  • You have access
    Outcome of Surgical Resection and Chemotherapy Versus Chemotherapy Alone for the Treatment of Isolated Primary Adrenal Lymphoma: A Retrospective Cohort Study of 16 Consecutive Patients
    GIULIO ILLUMINATI, PRISCILLA NARDI, CHIARA FRATINI, ROCCO PASQUA, CARLA GIORDANO, MARCO GIROLAMI and FABIO CARBONI
    Anticancer Research May 2021, 41 (5) 2647-2652; DOI: https://doi.org/10.21873/anticanres.15045
  • You have access
    ERCC1 Is a Predictive Biomarker for Non-small Cell Lung Cancer But Is Antibody-dependent
    TAMIO OKIMOTO, YUKARI TSUBATA, RYOSUKE TANINO, MIKA NAKAO, TAKAMASA HOTTA, MEGUMI HAMAGUCHI, SHUNICHI HAMAGUCHI, ASUKA ARAKI and TAKESHI ISOBE
    Anticancer Research May 2021, 41 (5) 2653-2660; DOI: https://doi.org/10.21873/anticanres.15046
  • You have access
    Prognostic Significance of EGFR Gene Mutation in Patients With EGFR Mutated Non-small Cell Lung Cancer Who Received Best Supportive Care Alone
    TAKESHI MASUDA, YU WAKABAYASHI, TAKU NAKASHIMA, YOSHIFUMI NISHIMURA, KIYOFUMI SHIMOJI, KAKUHIRO YAMAGUCHI, SHINJIRO SAKAMOTO, YASUSHI HORIMASU, SHINTARO MIYAMOTO, TADASHI SENOO, HIROSHI IWAMOTO, SHINICHIRO OHSHIMO, KAZUNORI FUJITAKA, HIRONOBU HAMADA and NOBORU HATTORI
    Anticancer Research May 2021, 41 (5) 2661-2667; DOI: https://doi.org/10.21873/anticanres.15047
  • You have access
    Clinicopathological Features of Growth Hormone-producing Pituitary Adenomas and Correlation With Preoperative Laboratory Findings
    IULIA FLORENTINA BURCEA, VALERIA NICOLETA NĂSTASE, ANCA MARIA CÎMPEAN, AMALIA RALUCA CEAUȘU, IONELA BACIU, CRISTINA CĂPĂȚÎNĂ, ROXANA DUSCEAC, SIMONA GĂLOIU, DAN NICULESCU, ȘERBAN RADIAN, RALUCA TRIFĂNESCU, ANDA DUMITRAȘCU, LAURENȚIU CĂTĂLIN COCOȘILĂ, MARIUS RAICA and CĂTĂLINA POIANĂ
    Anticancer Research May 2021, 41 (5) 2669-2680; DOI: https://doi.org/10.21873/anticanres.15048
  • You have access
    Postoperative Survival in Colitis-associated Colorectal Cancer With Ulcerative Colitis in Japan: A Multicenter Analysis
    AKIRA SUGITA, HIROKI IKEUCHI, YUUJI FUNAYAMA, KITARO FUTAMI, TSUNEO IIAI, MICHIO ITABASHI and YASUO SUZUKI
    Anticancer Research May 2021, 41 (5) 2681-2688; DOI: https://doi.org/10.21873/anticanres.15049
  • You have access
    Advanced Stages and Increased Need for Adjuvant Treatments in Breast Cancer Patients: The Effect of the One-year COVID-19 Pandemic
    GIANLUCA VANNI, MARCO PELLICCIARO, MARCO MATERAZZO, DOMIZIANA PEDINI, ILARIA PORTARENA, CHIARA BUONOMO, TOMMASO PERRETTA, STEFANO RIZZA, CHIARA ADRIANA PISTOLESE and ORESTE CLAUDIO BUONOMO
    Anticancer Research May 2021, 41 (5) 2689-2696; DOI: https://doi.org/10.21873/anticanres.15050
  • You have access
    Clinical Outcomes Among Major Breast Cancer Subtypes After Neoadjuvant Chemotherapy: Impact on Breast Cancer Recurrence and Survival
    PAOLO ORSARIA, ANTONELLA GRASSO, EDY IPPOLITO, FRANCESCO PANTANO, MATTEO SAMMARRA, CARLO ALTOMARE, BARBARA CAGLI, FABIO COSTA, GIUSEPPE PERRONE, GEORGETA SOPONARU, LORENZA CAGGIATI, GIANLUCA VANNI, ORESTE CLAUDIO BUONOMO and VITTORIO ALTOMARE
    Anticancer Research May 2021, 41 (5) 2697-2709; DOI: https://doi.org/10.21873/anticanres.15051
  • You have access
    Alpha-fetoprotein for Gastric Cancer Staging: An Essential or Redundant Tumor Marker?
    CHUN-YI TSAI, KENG-HAO LIU, CHENG-TANG CHIU, SHUN-WEN HSUEH, CHIA-YEN HUNG, JUN-TE HSU, NGAN-MING TSANG, YU-SHIN HUNG and WEN-CHI CHOU
    Anticancer Research May 2021, 41 (5) 2711-2718; DOI: https://doi.org/10.21873/anticanres.15052
  • You have access
    Dedifferentiated Mesonephric-like Adenocarcinoma of the Uterine Corpus
    SANGJOON CHOI, KIYONG NA, SO-WOON KIM and HYUN-SOO KIM
    Anticancer Research May 2021, 41 (5) 2719-2726; DOI: https://doi.org/10.21873/anticanres.15053
  • You have access
    Hepatic Inflammatory Pseudotumor Mimicking Malignant Tumor With Rare Onset of Intra-abdominal Hemorrhage
    KENSUKE YAMAMURA, TORU BEPPU, ERI ODA, NOBUTAKA SATO, HIDEAKI YUKI, TOSHIHIKO MOTOHARA, HIDEAKI MIYAMOTO, SHUNICHI MIYAMURA, KOJI ONISHI, YOSHIHIKO KOMOHARA and SHINICHI AKAHOSHI
    Anticancer Research May 2021, 41 (5) 2727-2732; DOI: https://doi.org/10.21873/anticanres.15054

Errata

  • You have access
    Errata
    Anticancer Research May 2021, 41 (5) 2733-2735;
Back to top
PreviousNext

In this issue

Anticancer Research: 41 (5)
Anticancer Research
Vol. 41, Issue 5
May 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • IL-39 Reduces Proliferation and Promotes Apoptosis of Bladder Cancer by Altering the Activity of Cyclin E and Fas
  • Combined Targeting of AKT and mTOR Synergistically Inhibits Formation of Primary Colorectal Carcinoma Tumouroids In Vitro: A 3D Tumour Model for Pre-therapeutic Drug Screening
  • Synergistic Effect of Bazedoxifene and PARP Inhibitor in the Treatment of Ovarian Cancer Regardless of BRCA Mutation
  • What Is the Clinical Impact of Sending Tissue for Histopathology During Surgery for Known, Diffuse Metastatic Disease to Bone?
  • Cutaneous Lesion of the Nose as Initial Presentation of Esophageal Adenocarcinoma
Sign up for alerts

Jump to

  • Reviews
  • Experimental Studies
  • Clinical Studies
  • Errata
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire